Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use.

NCT01894152 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01894152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01894152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use.
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
October 9, 2019
Enrollment
2,002 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, cardiovascular disease, coronary artery disease, coronary heart disease, coronary restenosis, myocardial infarction, stent thrombosis, vascular disease